■ 8/14일자 벨기에 계약 소식

유럽연합의 온라인 조달관보인 TED(Tenders Electronic Daily)에서 8/14일자 벨기에 계약 낙찰 공고가 1건 확인되네요

■ 490013-2024 벨기에
약품명은 Infliximab IV제형(Remsima:램시마)로 확인됩니다. 낙찰금액은 14억3천정도로 확인되며 계약일자는 8/10일입니다. 아래내용을 참고하세요

■ Results ---------------------------------
6.1.Result lot ldentifier: LOT-0001
Winner selection status: At least one winner was chosen.
6.1.2.Information
about winners

■ Winner: 
□ Official name: Celltrion Healthcare Netherlands B.V.
Tender identifier: INFLIXIMAB - CELLTRION
Identifier of lot or group of lots: LOT-0001
□ Value of the result: 957 609,60 EUR
Concession value: Subcontracting: No
Contract information: 
Identifier of the contract: INFLIXIMAB 24-28 - CELLTRION
□ Date of the conclusion of the contract: 10/08/2024
6.1.4.Statistical information: 
Range of tenders: 
□Value of the lowest admissible tender: 957 609,60 EUR
Value of the highest admissible tender: 1 033 073,40 EUR